A Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: HER2+ Cancer
Interventions: BIOLOGICAL: AVX901
Sponsor: H. Kim Lyerly
Collaborators: Susan G. Komen Breast Cancer Foundation